Lifordi

Lifordi Immunotherapeutics

This biotechnology company develops antibody-drug conjugates to deliver immunomodulatory treatments for patients with autoimmune and inflammatory disorders.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Ability Biologics

The company develops antibody biotherapeutics using artificial intelligence for patients with cancer, autoimmune and inflammatory diseases.

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Conveyor Therapeutics

This biotech company develops antibody drug conjugates to deliver immunosuppressive payloads for the treatment of immunological and inflammatory diseases in human patients.

ai3Bio

This biotechnology company develops lipid nanoparticle and antibody platforms that selectively eliminate disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Profound Bio

This clinical-stage biotechnology company develops antibody-drug conjugates and targeted therapies for patients with solid tumors and hematological malignancies.